other material
confidence high
sentiment neutral
materiality 0.40
Orchestra BioMed confirms SVB exposure less than 1% of total cash
Orchestra BioMed Holdings, Inc.
- Less than 1% of total cash, cash equivalents and marketable securities held at Silicon Valley Bank.
- Company states exposure to SVB is de minimis and not material.
- Filed investor slide presentation for Q1 2023; no material new disclosures beyond SVB update.